With the ultimate goal of accelerating the translation of selective, bioavailable and effective protein degraders into clinical trials, join us at Targeted Protein Degradation (TPD) Europe to capitalise on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.